Sustained delivery formulations of rapamycin compounds

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/08 (2006.01) A61P 37/06 (2006.01)

Patent

CA 2678176

The present invention relates to a rapamycin sustained release delivery system for treatment of diseases responsive to rapamycin. The sustained release delivery system of the invention includes a flowable composition containing rapamycin or a rapamycin derivative, which is capable of providing an implant containing the rapamycin or derivative thereof. The flowable composition may be injected into tissue whereupon it coagulates to become the solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid and rapamycin or a rapamycin derivative.

La présente invention concerne un système de libération et de distribution soutenue de rapamycine destiné au traitement de maladies sensibles à la rapamycine. Le système de libération et de distribution soutenue de l'invention comporte une composition liquide contenant de la rapamycine ou un dérivé de rapamycine, qui est capable de fournir un implant contenant de la rapamycine ou un dérivé de celle-ci. La composition liquide peut être injectée dans un tissu, après quoi elle coagule pour devenir l'implant monolithique solide ou gélifié. La composition liquide comporte un polymère thermoplastique biodégradable, un liquide organique et de la rapamycine ou un dérivé de rapamycine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sustained delivery formulations of rapamycin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained delivery formulations of rapamycin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained delivery formulations of rapamycin compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1860967

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.